August 14, 2022
1 min read
NuVasive Inc. has announced increased net sales in its second-quarter 2022 financial results, according to a company press release.
The company reported $310.5 million in net sales for the quarter, a 5.3% increase compared with $294.8 million in the prior year period. NuVasive also reported $224.7 million in gross profit.
“We are encouraged by our top-line growth in the second quarter, driven by procedure volumes, new product introductions and continued global execution of our growth strategies,” Chris Barry, CEO of NuVasive, said in the release. “As surgeons look for differentiated technologies to enable more intelligent surgery, our C360 portfolio, X360 portfolio and Pulse platform will continue to support our innovation strategy. While we are experiencing the macro environmental pressures that face many companies, we remain focused on our commitment to deliver value to all stakeholders — most importantly, to change the lives of more patients around the world.”